Javascript must be enabled to continue!
Axl, A Receptor Tyrosine Kinase, Mediates Flow-Induced Vascular Remodeling
View through CrossRef
Intima-media thickening (IMT) in response to hemodynamic stress is a physiological process that requires coordinated signaling among endothelial, inflammatory, and vascular smooth muscle cells (VSMC). Axl, a receptor tyrosine kinase, whose ligand is Gas6, is highly induced in VSMC after carotid injury. Because Axl regulates cell migration, phagocytosis and apoptosis, we hypothesized that Axl would play a role in IMT. Vascular remodeling in mice deficient in Axl (Axl
−/−
) and wild-type littermates (Axl
+/+
) was induced by ligation of the left carotid artery (LCA) branches maintaining flow via the left occipital artery. Both genotypes had similar baseline hemodynamic parameters and carotid artery structure. Partial ligation altered blood flow equally in both genotypes: increased by 60% in the right carotid artery (RCA) and decreased by 80% in the LCA. There were no significant differences in RCA remodeling between genotypes. However, in the LCA Axl
−/−
developed significantly smaller intima+media compared with Axl
+/+
(31±4 versus 42±6×10
−6
μm
3
, respectively). Quantitative immunohistochemistry of Axl
−/−
LCA showed increased apoptosis compared with Axl
+/+
(5-fold). As expected, p-Akt was decreased in Axl
−/−
, whereas there was no difference in Gas6 expression. Cell composition also changed significantly, with increases in CD45
+
cells and decreases in VSMC, macrophages, and neutrophils in Axl
−/−
compared with Axl
+/+
. These data demonstrate an important role for Axl in flow-dependent remodeling by regulating vascular apoptosis and vascular inflammation.
Ovid Technologies (Wolters Kluwer Health)
Title: Axl, A Receptor Tyrosine Kinase, Mediates Flow-Induced Vascular Remodeling
Description:
Intima-media thickening (IMT) in response to hemodynamic stress is a physiological process that requires coordinated signaling among endothelial, inflammatory, and vascular smooth muscle cells (VSMC).
Axl, a receptor tyrosine kinase, whose ligand is Gas6, is highly induced in VSMC after carotid injury.
Because Axl regulates cell migration, phagocytosis and apoptosis, we hypothesized that Axl would play a role in IMT.
Vascular remodeling in mice deficient in Axl (Axl
−/−
) and wild-type littermates (Axl
+/+
) was induced by ligation of the left carotid artery (LCA) branches maintaining flow via the left occipital artery.
Both genotypes had similar baseline hemodynamic parameters and carotid artery structure.
Partial ligation altered blood flow equally in both genotypes: increased by 60% in the right carotid artery (RCA) and decreased by 80% in the LCA.
There were no significant differences in RCA remodeling between genotypes.
However, in the LCA Axl
−/−
developed significantly smaller intima+media compared with Axl
+/+
(31±4 versus 42±6×10
−6
μm
3
, respectively).
Quantitative immunohistochemistry of Axl
−/−
LCA showed increased apoptosis compared with Axl
+/+
(5-fold).
As expected, p-Akt was decreased in Axl
−/−
, whereas there was no difference in Gas6 expression.
Cell composition also changed significantly, with increases in CD45
+
cells and decreases in VSMC, macrophages, and neutrophils in Axl
−/−
compared with Axl
+/+
.
These data demonstrate an important role for Axl in flow-dependent remodeling by regulating vascular apoptosis and vascular inflammation.
Related Results
Abstract 406: Mechanism of AXL regulation in chemotherapy resistance
Abstract 406: Mechanism of AXL regulation in chemotherapy resistance
Abstract
Constitutive activation of receptor tyrosine kinase AXL is an important phenomenon in chemotherapy resistance and is highly expressed in several malignancie...
Development of an Axl/Mer Dual Inhibitor, ONO-9330547: Promising Single Agent Activity in an Acute Myeloid Leukemia (AML) Model
Development of an Axl/Mer Dual Inhibitor, ONO-9330547: Promising Single Agent Activity in an Acute Myeloid Leukemia (AML) Model
Abstract
Purpose: Axl and Mer belong to the TAM (Tyro3, Axl, Mer) family of receptor tyrosine kinases and play a role in regulating cell proliferation, survival, mig...
Abstract 1572: Overexpression of Axl delays metastatic outgrowth of prostate cancer bone marrow disseminated tumor cells
Abstract 1572: Overexpression of Axl delays metastatic outgrowth of prostate cancer bone marrow disseminated tumor cells
Abstract
The presence of detectable metastases in the bone marrow of prostate cancer patients represents lethal, incurable disease. These metastases that may emerge ...
Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
Overexpression and amplification of AXL receptor tyrosine kinase (RTK) has been found in several hematologic and solid malignancies. Activation of AXL can enhance tumor-promoting p...
Abstract LB-259: The potent and selective Axl/Mer dual inhibitor ONO-9330547, shows promising single agent activity in non-small cell lung cancer (NSCLC)
Abstract LB-259: The potent and selective Axl/Mer dual inhibitor ONO-9330547, shows promising single agent activity in non-small cell lung cancer (NSCLC)
Abstract
Purpose: Axl and Mer are members of the TAM (Tyro3, Axl, Mer) receptor tyrosine kinase family and they play an important role in regulating cell proliferati...
Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
Phosphatidylinositol 3′-kinase associates with an insulin receptor substrate-1 serine kinase distinct from its intrinsic serine kinase
Serine phosphorylation of insulin receptor substrate-1 (IRS-1) has been proposed as a counter-regulatory mechanism in insulin and cytokine signalling. Here we report that IRS-1 is ...
Abstract 3806: Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer
Abstract 3806: Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer
Abstract
Anaplastic lymphoma kinase tyrosine kinase inhibitors (ALK-TKIs) induce a dramatic response in non-small cell lung cancer (NSCLC) patients with the ALK f...
Structural analysis of tilvestamab in complex with AXL
Structural analysis of tilvestamab in complex with AXL
Abstract
AXL is a receptor tyrosine kinase with a significant role in various biological processes and important medical implications, particularly in cancer. AXL trans...

